You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anti-Angiogenesis

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Solid Tumor, Adult, Solid Tumor, Gastric Cancer Trial in Seongnam, Seoul (PB101)

Recruiting
  • Solid Tumor, Adult
  • +5 more
  • Seongnam, Korea, Republic of
  • +2 more
Oct 11, 2023

SARS (Severe Acute Respiratory Syndrome) Trial in Sousse (Colloidal Silver, Placebo)

Recruiting
  • SARS (Severe Acute Respiratory Syndrome)
  • Colloidal Silver
  • Placebo
  • Sousse, Itinéraire Ceinture Cité Sahloul, Tunisia
    HU Sahloul, sousse, Tunisia
Jul 26, 2021

Hepatocellular Carcinoma Trial (PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • PD-1/PD-L1 inhibitors+VEGF-TKI/bevacizumab
  • TACE
  • Nanjing, China
  • +1 more
Dec 28, 2022

Risk of NSAIDs on Anastomotic Leak for Rectal Surgery

Recruiting
  • Anastomotic Leak
  • Anti-Inflammatory Agents, Non-Steroidal
    • Chongqing, None Selected, China
      Army Medical Center
    Nov 24, 2023

    NSCLC Trial (Sintilimab, Anlotinib)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    Mar 23, 2022

    B-cell Non-Hodgkin's Lymphoma Trial (IMM0306, Lenalidomide capsule)

    Not yet recruiting
    • B-cell Non-Hodgkin's Lymphoma
    • (no location specified)
    Mar 6, 2023

    Breast Cancer Trial in Guangzhou (Anlotinib)

    Not yet recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
      Guangdong Women and Children Hospital
    Jul 26, 2021

    Gingival Pigmentation Trial in Cairo (blue®m Gel, NBF GINGIVAL GEL®, COE-PAK™)

    Recruiting
    • Gingival Pigmentation
    • blue®m Gel
    • +2 more
    • Cairo, Egypt
      Cairo University
    Apr 27, 2023

    Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)

    Recruiting
    • Small Cell Lung Cancer
    • Beijing, Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    May 4, 2022

    Kaposiform Hemangioendothelioma, Tufted Angioma, Superficial Vascular Anomalies Trial in Shanghai (Percutaneous sirolimus, Oral

    Recruiting
    • Kaposiform Hemangioendothelioma
    • +3 more
    • Percutaneous sirolimus
    • Oral sirolimus
    • Shanghai, China
      Children's Hospital of Fudan University
    Jan 9, 2023

    Small Cell Lung Cancer Trial in Beijing (Chiauranib)

    Recruiting
    • Small Cell Lung Cancer
    • Beijing, Beijing, China
      Beijing Cancer Hospital
    Mar 8, 2022

    Gastric Cancer Metastatic to Liver Trial (Thalidomide Combined With Chemotherapy and Monotherapy)

    Not yet recruiting
    • Gastric Cancer Metastatic to Liver
    • Thalidomide Combined With Chemotherapy and Monotherapy
    • (no location specified)
    Jan 17, 2022

    Sarcoma,Soft Tissue Trial in Guangzhou (anlotinib and toripalimab)

    Recruiting
    • Sarcoma,Soft Tissue
    • anlotinib and toripalimab
    • Guangzhou, Guangdong, China
      Xing Zhang
    Nov 15, 2021

    Sarcoma Trial in Shanghai (MASCT-I,PD1 Antibody,Apatinib)

    Active, not recruiting
    • Sarcoma
    • MASCT-I,PD1 Antibody,Apatinib
    • Shanghai, Shanghai, China
      Shanghai Sixth People's Hospital
    Nov 22, 2022

    NSCLC Trial in Hangzhou (Amlotinib+Sindili)

    Recruiting
    • NSCLC
    • Hangzhou, Zhejiang, China
      Zhejiang Cancer Hospital
    Dec 30, 2020

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • +2 more
    • BD311
    • Shanghai, Shanghai, China
      Eye & ENT Hospital of Fudan University
    Aug 22, 2022

    Angiogenesis, Endometriosis Trial in Patra, Yonago (Leuprolide Acetate)

    Completed
    • Angiogenesis
    • Endometriosis
    • Leuprolide Acetate
    • Patra, Peloponnese, Greece
    • +1 more
    Oct 27, 2023

    Stage III NSCLC RWE in Chinese Patients

    Active, not recruiting
    • Carcinoma, Non-Small-Cell Lung
      • BeiJing, China
      • +24 more
      Dec 14, 2022

      Breast Cancer Trial in Xining (Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin)

      Recruiting
      • Breast Cancer
      • Sintilimab+Apatinib+Albumin-Bound Paclitaxel(Nab-Paclitaxel)+Carboplatin
      • Xining, Qinghai, China
        Affiliated Hospital of Qinghai University
      Apr 21, 2022

      Type 2 Diabetes Trial in Marseille (Liraglutide, Metformin or sulfonylurea)

      Completed
      • Type 2 Diabetes
      • Marseille, France
        Nutrition department, pole ENDO - Assistance Publique Hôpitaux M
      Jun 14, 2021

      Wheatgrass and Tulsi Formulation or Individuals Taken With Other

      Not yet recruiting
      • Blood Pressure, High
      • +3 more
      • Observation study
      • Pune, Maharashtra, India
        Sinhgad college of Pharmacy
      May 5, 2023

      Recurrent Neuroblastoma Trial in Germany (metronomic therapy)

      Recruiting
      • Recurrent Neuroblastoma
      • metronomic therapy
      • Bonn, Germany
      • +7 more
      Nov 3, 2022

      Differentiated Thyroid Cancer Trial in Nanjing, Peking (Apatinib Oral Tablet, Placebo Oral Tablet)

      Active, not recruiting
      • Differentiated Thyroid Cancer
      • Apatinib Oral Tablet
      • Placebo Oral Tablet
      • Nanjing, Jiangsu, China
      • +1 more
      Aug 9, 2021

      Unresectable Hepatocellular Carcinoma Trial (Huaier granule, Atezolizumab + Bevacizumab, Camrelizumab+Apatinib)

      Not yet recruiting
      • Unresectable Hepatocellular Carcinoma
      • Huaier granule
      • +3 more
      • (no location specified)
      Dec 20, 2022